Informal Caregivers' Administration of Opiate, Benzodiazepine, and Antipsychotic Medications to Home Hospice Patients Experiencing Hyperactive Delirium in the Last Week of Life.

Authors

Hannah B Kimball, Carol S Weisse, Georgia Doing, Kelly Melekis

Published in

The American journal of hospice & palliative care. Pages 10499091261500745. Oct 21, 2026. Epub Oct 21, 2026.

Abstract

PurposeWhile hospice-prescribed comfort medications are used to manage hyperactive delirium (HD), the relationship between caregivers' administration of these medications and HD is not well established, especially for patients receiving care in home settings.MethodsA retrospective chart review was conducted on medication records of home-hospice patients (N = 19) experiencing HD in the last week of life. Medication use included scheduled and prn medications administered and converted to opiate, benzodiazepine, and antipsychotics dose equivalencies. A binomial generalized linear model predicting HD incidents by dose equivalencies and time from death was followed by Spearman correlation lag analyses to characterize associations between HD and medications.ResultsThere were 2016 documented medication administrations and 133 HD incidents in the last week of life. After adjusting for covariation in measurements by patient, no medication class was a strong, independent predictor of HD. Opioid dose had a significant but modest positive association with HD incidents, but trends varied across patients. Shift-level lag analyses revealed HD episodes correlated with opioid and benzodiazepine doses in subsequent shifts more so than with doses in prior shifts, but neither lag transformation correlated more strongly than concurrent shift dose administration and HD.ConclusionsThe results highlight the intensity of pharmacologic management informal caregivers can face when managing HD in the last week without clinical staff on site. None of the 3 drug classes studied showed an inverse relationship to HD, raising questions about the efficacy of these medications for managing HD at the very end-of-life.

PMID:
42902770
Bibliographic data and abstract were imported from PubMed on 22 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.